005690.KS
Pharmicell Co., Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 9,800.00
−4.20%Forward multiples
Based on analyst estimates
- P/E forward
- 35.77x
- P/E 2026E
- 9.52x
- P/E 2027E
- 7.70x
- P/E 2028E
- —
- P/S forward
- 13.10x
Trailing multiples
Trailing twelve months
- P/E TTM
- 12.63x
- PEG TTM
- 0.24x
- Price / book
- 4.10x
- Price / sales
- 4.33x
- Price / cash flow
- 14.34x
Enterprise value
- Enterprise value
- KRW 547.9B
- EV / sales
- 4.03x
- EV / EBITDA
- 11.66x
- EV / EBIT
- 12.45x
- Market cap
- KRW 588.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026